Skip to main content

ORIGINAL RESEARCH article

Front. Cell Dev. Biol., 09 February 2021
Sec. Molecular and Cellular Oncology
Volume 9 - 2021 | https://doi.org/10.3389/fcell.2021.568738
This article is part of the Research Topic Exploring Metabolic Reprogramming in the Epithelial-Mesenchymal Transition in Cancer: New Perspectives in Therapy, Drug Discovery and Diagnostics View all 10 articles

RETRACTED: Exosomal miR-128-3p Promotes Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cells by Targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 Signaling

Retracted

A retraction of this article was approved in:

  1. Retraction: Exosomal miR-128-3p promotes epithelial-to-mesenchymal transition in colorectal cancer cells by targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 signaling

    1. Read retraction
\nJian Bai,,,&#x;Jian Bai1,2,3,4†Xue Zhang,,,&#x;Xue Zhang3,4,5,6†Dongdong Shi,,&#x;Dongdong Shi1,3,4†Zhenxian Xiang,,Zhenxian Xiang1,3,4Shuyi Wang,,Shuyi Wang1,3,4Chaogang Yang,,Chaogang Yang1,3,4Qing Liu,,Qing Liu1,3,4Sihao Huang,,Sihao Huang1,3,4Yan Fang,,Yan Fang1,3,4Weisong Zhang,,Weisong Zhang1,3,4Jialin Song,,Jialin Song1,3,4Bin Xiong,, Bin Xiong1,3,4*
  • 1Department of Gastrointestinal Surgery & Department of Gastric and Colorectal Surgical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China
  • 2Department of Anesthesiology, Peking University Third Hospital, Beijing, China
  • 3Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan, China
  • 4Hubei Cancer Clinical Study Center, Wuhan, China
  • 5Department of General Practice, Beijing Friendship Hospital, Capital Medical University, Beijing, China
  • 6Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Bai J, Zhang X, Shi D, Xiang Z, Wang S, Yang C, Liu Q, Huang S, Fang Y, Zhang W, Song J and Xiong B (2021) Exosomal miR-128-3p Promotes Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cells by Targeting FOXO4 via TGF-β/SMAD and JAK/STAT3 Signaling. Front. Cell Dev. Biol. 9:568738. doi: 10.3389/fcell.2021.568738

Received: 02 June 2020; Accepted: 07 January 2021;
Published: 09 February 2021; Retracted: 19 July 2024.

Edited by:

Lorena Pochini, University of Calabria, Italy

Reviewed by:

Arunkumar Ganesan, National Cancer Institute (NCI), United States
Soichiro Yamamura, University of California, San Francisco, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.